Delving Deeper into Genotypic–Phenotypic Associations in Idiopathic Pulmonary Fibrosis

The past 2 decades have witnessed considerable progress in our deciphering the genetic underpinnings of idiopathic pulmonary fibrosis (IPF). Advances in genetic research such as the discovery of the MUC5B promoter variant, telomere-related gene mutations, and the interplay of genetics with environmental exposures have redefined our understanding of IPF susceptibility and progression (1). These insights highlight how genetic predisposition and external factors converge to shape molecular pathogenesis, paving the way for precision medicine in pulmonary fibrosis. Similarly, the past decade has seen major advances in the development of deep-learning algorithms and their application to IPF (2). Indeed, several deep-learning methodologies have been shown to diagnose usual interstitial pneumonia pattern (UIP) on high-resolution computed tomography (HRCT) with a higher accuracy than radiologist interpretation (3, 4). The advent of computational HRCT phenotyping provides an opportunity to examine associations between genetic variant status and disease characteristics.

In this issue of the Journal, Blumhagen and colleagues (pp. 533–540) provide important insight into genotypic-phenotypic relationships in IPF (5). The authors utilized a study population assembled from several cohorts comprising 876 participants with IPF, all of whom had genotype data and chest CT imaging data available for analysis. Ten IPF-associated genetic variants, including MUC5B, TERT, and TERC, were examined. CT images were analyzed using two deep-learning algorithms: data-driven textural analysis (DTA) and multiple-instance learning (MIL) UIP (MIL-UIP). Higher DTA fibrosis and MIL-UIP scores have been previously associated with worse outcomes in IPF (6, 7). The MIL-UIP algorithm, which emphasizes anterior, mid-, and upper lung zones, demonstrates a unique ability to detect patterns that are not traditionally associated with visual UIP assessments, and it has been shown to outperform visual assessment for predicting histologic UIP, thereby challenging conventional imaging paradigms (7). This approach, combined with the use of a continuous MIL-UIP score, enabled the detection of nuanced associations with genotype that were not otherwise apparent.

Blumhagen and colleagues had several critical findings that underscore the potential of computational imaging in uncovering genotype–phenotype relationships in IPF. First, they demonstrated that variants in MUC5B and ZKSCAN1 were significantly associated with the MIL-UIP score on multivariate analysis, highlighting a robust link between these genetic loci and computationally derived UIP patterns. Additionally, a composite genetic risk score reflecting the cumulative number of risk variants was also associated with MIL-UIP scores, although this finding was driven primarily by MUC5B status, emphasizing its dominant role in IPF susceptibility. Second, their study revealed that the presence of a radiologist-determined UIP pattern correlated with both higher MIL-UIP scores and increased DTA fibrosis scores, reinforcing the association of traditional visual assessments with computational imaging metrics. Third, and perhaps most intriguingly, they found no association between genetic variant status and either radiologist-determined UIP patterns or fibrosis severity as measured by DTA scores, in contrast to prior studies (8–10). This may reflect differences in the patient cohorts studied or variation in radiologist interpretation of UIP patterns.

This study represents a pivotal step forward in integrating genetic insights with advanced computational imaging to deepen our understanding of IPF. By uncovering novel associations between genetic variants, such as MUC5B and ZKSCAN1, and computationally derived UIP patterns, these findings highlight the unique potential of machine-learning algorithms to reveal genotype–phenotype relationships beyond the reach of traditional imaging or fibrosis severity assessments (Figure 1). These results also illustrate the value of advanced imaging algorithms such as MIL-UIP in expanding our understanding of how genetic predisposition influences disease phenotypes in IPF. This study also raises important questions about the clinical implications of these associations, particularly in light of the paradoxical observation that the MUC5B GG genotype—previously reported to be associated with reduced survival—was linked to lower MIL-UIP scores (11). This suggests that while computational imaging offers a powerful tool for uncovering genetic insights, the complex interplay between genotype, disease progression, and imaging features requires further exploration. By integrating computational imaging with genetic analyses, this study provides a promising framework for advancing precision medicine in pulmonary fibrosis management.

Figure 1.

Schematic representation of the interplay between idiopathic pulmonary fibrosis (IPF) genetic risk variants, genetic susceptibility influenced by gene–environment interactions, and their contributions to genotypic–phenotypic variation in pulmonary fibrosis. Computationally derived usual interstitial pneumonia (UIP) and radiologist-visualized UIP illustrate complementary pathways for understanding IPF heterogeneity, enabling advancements in precision medicine.

Despite its strengths, this study has limitations that temper the immediate applicability of its findings. Approximately one-third of participants had CT data that were amenable to computational analysis, which restricts the generalizability of the results. Additionally, 14% of the cohort had familial interstitial pneumonia, known for considerable radiologic and pathologic heterogeneity (12), which may have confounded the detection of associations between CT patterns—both computational and visual—and genetic variants. Furthermore, the timing of CT imaging during the disease course may have influenced visual classification outcomes, particularly in early IPF when UIP patterns on HRCT may be less defined. These factors, coupled with the cross-sectional study design and lack of pulmonary function and survival data, highlight the need for longitudinal studies and external validation to solidify and build on these genotypic and phenotypic associations.

Future research should prioritize external validation of these findings in diverse and independent cohorts, with an emphasis on longitudinal designs that capture the temporal evolution of IPF phenotypes. Incorporating data on treatment status and outcomes will also be essential to better delineate the interplay between pharmacologic interventions, genetic risk, and imaging features. Computational imaging could, one day, facilitate earlier and more accurate identification of high-risk genetic profiles, offering a pathway to personalized management that aligns therapeutic decisions with individual disease biology. This work paves the way for a future where computational imaging, genetics, and genomics converge to advance precision medicine in pulmonary fibrosis. Bridging genetic predisposition with advanced phenotyping tools holds the promise of transforming both patient care and disease outcomes in IPF.